Wearable exoskeleton to support walking and balance in older adults and people with Parkinson's
Official title: Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease: A Mixed-Methods Study of Effectiveness and Acceptability
Run by Centre intégré de santé et de services sociaux de l'Outaouais · NCT07567482 · Data updated 2026-11-12
This project will test whether a wearable robotic exoskeleton can help older adults and people with Parkinson's walk steadier, improve balance, and reduce effort.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 26 (estimated) |
| Sponsor | Centre intégré de santé et de services sociaux de l'Outaouais Government |
| Locations | 1 site (Gatineau, Quebec) |
| Status | Recruiting |
| Started | April 30, 2026 |
| Main results expected | October 2026 |
| Study ends | November 2026 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT07567482 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 65 or older who can walk for at least 30 minutes and people with idiopathic Parkinson's disease (Hoehn and Yahr stages 1–4) who do not have severe cognitive impairment.
✕Probably not a fit
People with severe vascular disease of the lower limbs, severe osteoporosis or high fracture risk, implantable life‑support devices (e.g., pacemaker), severe cognitive impairment, other neurological or lower‑limb conditions that limit mobility, or height under 152 cm are excluded and therefore unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants attend two in-person laboratory sessions that include clinical assessments, fitting and familiarization with a wearable exoskeleton, and interviews about user perceptions. In the second session, participants perform functional mobility tasks — such as walking, standing, and turning — both with and without the exoskeleton and at different assistance levels while movement is recorded with wearable sensors. The study measures immediate effects on objective gait and balance metrics, compares different assistance settings to each participant's preferred level, and identifies participant characteristics associated with benefit. Results will also inform user experience and acceptability to guide future implementation of assistive mobility technologies.
Why it matters
Potential benefit: If successful, the exoskeleton could improve walking speed and balance, reduce effort and fall risk, and support greater independence for older adults and people with Parkinson's.
How similar studies have gone: Wearable exoskeletons have shown promise improving gait and reducing effort in older adults and other groups, but rigorous evidence specifically in Parkinson's disease is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Participants with Parkinson's disease Inclusion Criteria: * Ability to walk for at least 30 minutes with or without minimal aid * Diagnosis of idiopathic Parkinson's disease * Hoehn and Yahr stage 1 to 4 Exclusion Criteria: * Height smaller than 152 cm * Severe vascular conditions of the lower limbs that may limit mobility or pose a risk. * Presence of any implantable or external life-sustaining medical device such as a pacemaker * Severe osteoporosis or high risk of fractures * Contra-indication to the required physical effort * Severe cognitive impairment (MoCA \< 21) * Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility, other than Parkinson's disease. Healthy elderly participants without Parkinson's disease Inclusion Criteria: * Ability to walk for at least 30 minutes with or without minimal aid * Age ≥ 65 years old Exclusion Criteria: * Height smaller than 152 cm * Severe vascular conditions of the lower limbs that may limit mobility or pose a risk. * Presence of any implantable or external life-sustaining medical device such as a pacemaker * Severe osteoporosis or high risk of fractures * Contra-indication to the required physical effort * Severe cognitive impairment (MoCA \< 21) * Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility
Where it's running
-
TechCare Research Lab - CISSS de l'Outaouais
Gatineau, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Alexandra Potvin-Desrochers, PhD
- Email: alexandra.potvin-desrochers@ssss.gouv.qc.ca
- Phone: 819-966-6200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
-
Brain alpha-synuclein PET imaging in Parkinson's patients and healthy seniors
This open-label study tests a radioactive tracer called [18F]MK-0947 to see how it behaves in the brains of people with Parkinson's disease compared with healthy elderly volunteers.
-
Parkinson’s self-sufficiency and rehabilitation in a Czech spa setting
This intervention tests whether a Czech self-sufficiency test can be used with people with Parkinson’s disease and sees how spa-based rehabilitation affects independence, cognition, balance, and walking.
-
Imaging PD progression with [18F]AV-133 using high- and standard-resolution PET
This study tests how [18F]AV-133 PET imaging changes over 12 months in people with Parkinson's disease and a small group of healthy controls.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Sleep and adaptive DBS in Parkinson’s disease
This study tests whether adjusting adaptive deep brain stimulation during sleep can improve sleep quality and brain activity in people with Parkinson’s disease who already have DBS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.